Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
73.44 USD | +0.25% | +9.05% | +27.01% |
05:35pm | Daiwa Adjusts Price Target on Boston Scientific to $81 From $73 | MT |
02:36pm | Redburn Atlantic Adjusts Price Target on Boston Scientific to $79 From $75 | MT |
Evolution of the average Target Price on Boston Scientific Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Boston Scientific Corporation
Mizuho Securities | |
UBS | |
Oppenheimer | |
Bernstein | |
Deutsche Bank Securities | |
Baird | |
JPMorgan Chase | |
Raymond James | |
Wolfe Research | |
CL King | |
Canaccord Genuity | |
Barclays | |
Wells Fargo Securities | |
Truist Securities | |
Needham & Co. | |
RBC Capital Markets | |
BTIG | |
Morgan Stanley | |
Evercore ISI | |
Jefferies & Co. | |
Stifel Nicolaus | |
Citigroup | |
Piper Sandler | |
Nephron Research | |
Argus | |
TD Cowen | |
Goldman Sachs | |
BofA Securities | |
SVB Leerink | |
Credit Suisse | |
Atlantic Equities |
EPS Revisions
- Stock Market
- Equities
- BSX Stock
- Consensus Boston Scientific Corporation